ICM
AVNS

Invenomic Capital Management’s Avanos Medical AVNS Stock Holding History

Invenomic Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-119,605
Closed -$2.68M – 150
2023
Q4 		$2.68M Sell
119,605
-36,331
-23% -$750K 0.12% 136
2023
Q3 		$3.15M Buy
+155,936
New +$3.54M 0.13% 112

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invenomic Capital Management's AVNS Position: Q1 2024 in Review

Invenomic Capital Management sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 119,605 shares — an estimated $2.68M sold.

Invenomic Capital Management first reported a position in AVNS in Q3 2023 and held it in 2 quarters. The position peaked at $3.15M in Q3 2023. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • Invenomic Capital Management reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 119,605 Avanos Medical shares in Q1 2024, an estimated $2.68M.
  • Invenomic Capital Management first reported a position in Avanos Medical in Q3 2023 and held it in 2 quarters.
  • Invenomic Capital Management's Avanos Medical position peaked at $3.15M in Q3 2023.
  • 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.